PharmaVoice 100 logo

Retrophin President and Chief Executive Officer Eric Dube Named to the 2020 PharmaVOICE 100

SAN DIEGO (August 3, 2020) – Retrophin,  Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., president  and chief  executive officer, has been named by PharmaVOICE magazine to the 2020 PharmaVOICE 100 – an award that recognizes the 100 Most Inspiring People in the life sciences industry. Read the press release >
Travere Circle Logo

Retrophin Reports Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today reported its second quarter 2020 financial results and provided a corporate update. Read the press release >
Marshall Summar, M.D., CNRDI

Connecting More People to Optimal Rare Disease Care

An update on our partnership with Children's National Rare Disease Institute.
Rare Revolution Logo

Eric Dube, Ph.D., Interviewed by Rare Revolution

July 1, 2020 -- Our CEO and president Eric Dube, Ph.D., recently spoke with Rare Revolution Magazine about motivation, inspiration, challenges and hope.